PGFC
VRTX icon

Peapack-Gladstone Financial Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Buy
1,654
+25
+2% +$11.1K 0.01% 436
2026
Q1 		$728K Buy
1,629
+25
+2% +$11.7K 0.01% 434
2025
Q4 		$727K Sell
1,604
-7
-0.4% -$3.02K 0.01% 439
2025
Q3 		$630K Buy
1,611
+15
+0.9% +$6.27K 0.01% 469
2025
Q2 		$711K Sell
1,596
-181
-10% -$83.4K 0.01% 431
2025
Q1 		$861K Sell
1,777
-408
-19% -$190K 0.01% 409
2024
Q4 		$879K Sell
2,185
-1
-0% -$464 0.01% 402
2024
Q3 		$1.02M Buy
2,186
+120
+6% +$57.6K 0.01% 390
2024
Q2 		$968K Buy
2,066
+548
+36% +$238K 0.01% 397
2024
Q1 		$634K Buy
1,518
+185
+14% +$78.2K 0.01% 452
2023
Q4 		$542K Buy
1,333
+130
+11% +$48K 0.01% 473
2023
Q3 		$417K Hold
1,203
– – 0.01% 506
2023
Q2 		$423K Sell
1,203
-267
-18% -$90K 0.01% 510
2023
Q1 		$463K Buy
1,470
+50
+4% +$15K 0.01% 498
2022
Q4 		$410K Sell
1,420
-130
-8% -$39.6K 0.01% 492
2022
Q3 		$449K Hold
1,550
– – 0.01% 472
2022
Q2 		$437K Hold
1,550
– – 0.01% 458
2022
Q1 		$402K Buy
1,550
+50
+3% +$11.9K 0.01% 505
2021
Q4 		$330K Hold
1,500
– – 0.01% 545
2021
Q3 		$272K Buy
+1,500
New +$293K 0.01% 559

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Peapack-Gladstone Financial Corp's VRTX Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp increased its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q2 2026, buying an estimated $11.1K and bringing the position to 1,654 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #436.

Peapack-Gladstone Financial Corp first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.02M in Q3 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 1,654 shares of Vertex Pharmaceuticals worth $822K as of Q2 2026.
  • Peapack-Gladstone Financial Corp bought 25 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Vertex Pharmaceuticals made up 0.01% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #436 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Peapack-Gladstone Financial Corp's Vertex Pharmaceuticals position peaked at $1.02M in Q3 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.